Literature DB >> 10998953

Comparison of drinking patterns measured by daily reports and timeline follow back.

J S Searles1, J E Helzer, D E Walter.   

Abstract

The major objective of this study was to compare near real-time daily alcohol consumption data over the course of 366 consecutive days with retrospective reports by means of the timeline follow-back (TLFB). Participants (N = 33) responded for 366 days on an interactive voice response (IVR) system by entering alcohol consumption data daily using the touch-tone pads of their telephones. In-person interviews were conducted every 13 weeks during which participants were administered the TLFB. The correlations between the IVR and TLFB for amount consumed, drinking days, and heavy drinking days were modest. There was a wide variability across participants in their individual correlations for these variables. Participants who were diagnosable with a lifetime DSM-IV alcohol disorder at baseline significantly underreported their drinking compared with participants who were not diagnosable. The authors were unable to ascertain variables that influenced accurate reporting on the TLFB.

Entities:  

Mesh:

Year:  2000        PMID: 10998953     DOI: 10.1037//0893-164x.14.3.277

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  53 in total

1.  Do daily interactive voice response reports of smoking behavior correspond with retrospective reports?

Authors:  Benjamin A Toll; Ned L Cooney; Sherry A McKee; Stephanie S O'Malley
Journal:  Psychol Addict Behav       Date:  2005-09

2.  Correspondence between Interactive Voice Response (IVR) and Timeline Followback (TLFB) reports of drinking behavior.

Authors:  Benjamin A Toll; Ned L Cooney; Sherry A McKee; Stephanie S O'Malley
Journal:  Addict Behav       Date:  2005-06-21       Impact factor: 3.913

3.  A within-subjects validation of a group-administered timeline followback for alcohol use.

Authors:  Eric R Pedersen; Joseph W LaBrie
Journal:  J Stud Alcohol       Date:  2006-03

4.  New insights into the efficacy of naltrexone based on trajectory-based reanalyses of two negative clinical trials.

Authors:  Ralitza Gueorguieva; Ran Wu; Brian Pittman; Joyce Cramer; Robert A Rosenheck; Stephanie S O'malley; John H Krystal
Journal:  Biol Psychiatry       Date:  2007-01-16       Impact factor: 13.382

5.  Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial.

Authors:  Charles S Cleeland; Xin Shelley Wang; Qiuling Shi; Tito R Mendoza; Sherry L Wright; Madonna D Berry; Donna Malveaux; Pankil K Shah; Ibrahima Gning; Wayne L Hofstetter; Joe B Putnam; Ara A Vaporciyan
Journal:  J Clin Oncol       Date:  2011-01-31       Impact factor: 44.544

6.  Effects of Recent Alcohol Consumption Level on Neurocognitive Performance in HIV+ Individuals.

Authors:  Kara R Douglas-Newman; Rachel V Smith; Mary V Spiers; Timothy Pond; Henry R Kranzler
Journal:  Addict Disord Their Treat       Date:  2017-09

7.  The theory of planned behavior as a predictor of growth in risky college drinking.

Authors:  Susan E Collins; Katie Witkiewitz; Mary E Larimer
Journal:  J Stud Alcohol Drugs       Date:  2011-03       Impact factor: 2.582

8.  Timeline: A web application for assessing the timing and details of health behaviors.

Authors:  Tyler B Wray; Alexander C Adia; Ashley E Pérez; Erik M Simpanen; Laura-Allison Woods; Mark A Celio; Peter M Monti
Journal:  Am J Drug Alcohol Abuse       Date:  2018-05-14       Impact factor: 3.829

9.  Concurrent Treatment of Substance Abuse, Child Neglect, Bipolar Disorder, Post-Traumatic Stress Disorder, and Domestic Violence: A Case Examination Involving Family Behavior Therapy.

Authors:  Brad C Donohue; Valerie Romero; Karen Herdzik; Holly Lapota; Ruwida Abdel Al; Daniel N Allen; Nathan H Azrin; Vincent B Van Hasselt
Journal:  Clin Case Stud       Date:  2009-10-24

10.  Applications of calendar instruments in social surveys: a review.

Authors:  Tina Glasner; Wander van der Vaart
Journal:  Qual Quant       Date:  2007-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.